Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Invasive Bladder Cancer × Lidocaine × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7 Pain 2 Agnosia 2 Urinary Bladder Neoplasms 1 Prostate Biopsy 1 Localised Prostate Cancer 1 Kidney Neoplasms 1 Invasive Bladder Cancer 1

Interventions

tremelimumab 1 durvalumab 1 Sodium Chloride 1 Radiotherapy 1 Lidocaine 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cystectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02924480 2022-03-09

Lidocaine

CAMC Health System

Phase NA Completed

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡